Aid for brain-bleed recovery receives expedited review
A noninvasive neuromodulation technology has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for reducing a dangerous narrowing of blood vessels in the brain that can follow a brain bleed from a ruptured aneurysm.